Safety and Immunogenicity of sIPV in Healthy Infants Aged 2 Months Following Sequential Immunization Program Combination with bOPV: A Phase 3, Randomized, Blinded, Parallel Positive-Controlled Clinical Trial

<b>Objectives</b>: This phase 3 clinical trial aimed to evaluate the safety and immunogenicity of the Sabin inactivated poliovirus vaccine (sIPV) manufactured by Biominhai in healthy infants following a sequential immunization regimen. <b>Methods</b>: A total of 300 healthy infants aged 2 months wer...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Yafei Liu, Xiaodong Liu, Li Zhang, Xianyun Chang, Ping Xiong, Yanxin Guan, Yixin Li, Weiling Zhang, Lili Xuan, Yan Li, Zhifang Ying, Qing Xu
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2025-10-01
سلاسل:	Vaccines
الموضوعات:	safety immunogenicity sIPV bOPV sequential immunization
الوصول للمادة أونلاين:	https://www.mdpi.com/2076-393X/13/11/1094
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!